ConocoPhillips

Revenue declined +28.5% YoY to $56.14B. 5-year revenue CAGR +8.9%; 10y CAGR +0.1%. Net margin at 19.52% (expanding ▲).

• Revenue declined +28.5% YoY to $56.14B.
• 5-year revenue CAGR +8.9%; 10y CAGR +0.1%.
• Net margin at 19.52% (expanding ▲).
• Return on equity 22.83%, ROA 11.42%, ROIC 0.00%.
• Gross margin 0.00%, operating margin 0.00%.
• Net income down ▼ +41.3% YoY.
• Debt/equity 0.35, current ratio 1.29, net debt $16.92B.
• Asset turnover 0.46 — capital efficiency.

Latest annual report (10-K) filed Feb 17, 2026. Latest quarterly report (10-Q) filed Apr 30, 2026. 8 recent 8-K material-event filings in the index.

• Latest annual report (10-K) filed Feb 17, 2026.
• Latest quarterly report (10-Q) filed Apr 30, 2026.
• 8 recent 8-K material-event filings in the index.
• Recent insider Form 4s: 0 buy vs 0 sell transactions.
• ~10,000+ recent 13F-HR filings reference ConocoPhillips; broad institutional reporting.
• Recent filers include Vermillion Asset Management LLC, Allen Investment Management LLC, INVESTORS TRUST CO /PA.
• 17 recent 13D activist/beneficial-ownership filings — potential catalyst.
• 3 recent 13G passive institutional ownership notices.

6 risk signal(s), 2 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. Revenue grew -28.5% but receivables grew +22.3% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.

• Receivables outpacing revenue: Accounts receivable grew +22.3% YoY vs revenue growth of -28.5%. The +50.8% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
• Inventory buildup exceeds sales growth: Inventory grew +29.4% vs revenue -28.5%. Excess inventory may signal weakening demand, potential write-downs, or supply chain overcommitment. Watch gross margin for discounting impact.
• Free cash flow deteriorating: FCF declined +29.7% YoY (from $21.68B to $15.25B). With OCF at $19.96B and capex at $4.71B, cash generation capacity is weakening — monitor for dividend/buyback sustainability.
• NEW: Going concern doubt in latest filing: The term "going concern" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 14 filing(s).
• Material weakness in internal controls: The term "material weakness" appears in 20 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
• NEW: Restatement of financial statements in latest filing: The term "restate" "financial statements" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 2 filing(s).
• Endogenous analysis: Revenue grew -28.5% but receivables grew +22.3% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
• Endogenous analysis: Free cash flow deterioration coincides with a -28.9% capex reduction. While lower capex temporarily preserves cash, it may signal underinvestment in growth assets — future revenue capacity could be constrained.
• Endogenous analysis: Strong cash conversion (OCF > NI) combined with growing deferred revenue provides high forward visibility. The business model appears to generate sustainable, recurring cash flows — a positive structural indicator.
• 1 new XBRL disclosure(s) in latest filing — expanding reporting scope.
• 20 disclosure(s) dropped from prior year — reduced reporting granularity.
• 3 new risk-language term(s) detected in filing text: Going concern doubt, Restatement of financial statements, Off-balance sheet arrangements.
• Ongoing high-severity risk language: Material weakness in internal controls.